SOP 01
Blog
ChatGPT Ads for hair transplant clinics: what we know two weeks in
2026-08-14
OpenAI opened self-serve Ads Manager access across nine countries in August 2026. Here's what's actually usable today, and what still isn't.
SOP 02
OpenAI began rolling out self-serve access to ChatGPT Ads Manager on 1 August 2026, starting with nine countries: the United States, United Kingdom, Canada, Australia, Germany, France, Spain, Mexico and Brazil. Access is invite-gated for most advertisers, with waitlist approvals arriving in batches through August. As of this writing, our Mexico City accounts have been live for thirteen days.
This update is written for clinic owners who are being pitched ChatGPT Ads by agencies or who are considering applying for access themselves. We are not going to speculate about where this channel will be in six months. We are reporting what we have seen running live campaigns for hair restoration clients since the access opened.
What is confirmed and working
Ads currently appear in three placements: within ChatGPT's conversational responses when a user's query is commercially relevant, in the "Shopping" style result cards for product and service queries, and in a dedicated sidebar unit on desktop. Placement is determined by OpenAI's own relevance model, not by manual targeting choices in the way Google Search Ads targets exact match keywords.
Targeting is limited to five inputs at launch:
Broad topic categories (health, medical procedures, aesthetics)
Country and, in a subset of markets including Mexico, city-level geo targeting
Device type
Daily budget caps, set in the advertiser's local currency
A single creative format: short text response plus one image and one link
Billing runs on a cost-per-click basis only. There is no cost-per-impression or cost-per-conversion bidding option yet. CPCs on our live hair restoration campaigns in Mexico City have ranged from $1.10 to $3.40 USD equivalent, which sits below our current Google Search CPCs for the same procedure terms and above our Meta CPCs for cold audiences.
What is not yet available
Conversion tracking is the largest gap. There is no native pixel or server-side conversion API at this stage. OpenAI has stated a conversions API is "in development" with no published date. Without it, attribution depends on UTM parameters and whatever your own CRM and call tracking can stitch together manually. We are doing this today for clients on this channel, but it is a manual weekly reconciliation, not an automated dashboard.
There is no retargeting or audience list upload. You cannot exclude people who already booked a consultation, and you cannot build a lookalike audience from your existing patient list. Every impression is served against OpenAI's own topic and intent signals, not your first-party data.
There is no A/B testing tool inside Ads Manager. Creative testing means manually pausing one ad and launching another, then comparing performance across non-concurrent time windows, which is a weaker test design than a true split test.
Reporting is limited to impressions, clicks, CPC and spend. There is no on-platform conversion, lead or revenue reporting. Demographic breakdowns (age, gender) are not exposed to advertisers at all at this stage, which matters for a procedure with a known demographic skew.
What this means for a hair restoration clinic specifically
The queries that trigger hair restoration ad placements are almost entirely informational at this stage: "does hair transplant work," "FUE vs FUT recovery," "hair transplant cost Mexico City." These are early-funnel questions, not "book a consultation" queries. That matches what we would expect two weeks into a new ad product, where the advertiser base and the query volume for commercial-intent terms are still both thin.
Because there is no retargeting and no native conversion tracking, ChatGPT Ads today functions closer to a top-of-funnel awareness channel than a direct-response booking channel. Clinics used to judging Google Search Ads or Meta Ads by cost per booked consultation will not have an equivalent number to look at yet on this channel. Any agency presenting a cost-per-consultation figure for ChatGPT Ads in August 2026 is either using a proxy metric or making an estimate, not reading it off the platform.
Our own approach for clients evaluating this channel has been to route ChatGPT Ads clicks through the same call tracking and CRM tagging we use for Google and Meta, treat the channel as a small test budget alongside proven channels rather than a replacement for them, and hold it to a longer measurement window given the manual attribution work involved.
A source note on the numbers used in this update:
The CPC ranges and query examples above come from active Growthdoc client accounts running in Mexico City between 1 and 13 August 2026. They are not published OpenAI benchmarks and should not be read as guaranteed figures for a new account, a different market, or a different procedure category. Platform availability, targeting options and reporting are described as of 14 August 2026 and are subject to change as OpenAI continues to roll out Ads Manager features.
Practical guidance if you are considering applying
Apply for access now if you want to be positioned early, but budget it as a test line, not a core acquisition channel, for at least the next full quarter. Do not expect a cost-per-consultation number from the platform itself. Build your own tagging and reconciliation before you spend a single dollar, because there is nothing native to fall back on. Treat top-of-funnel informational queries as the current reality of this channel, not a limitation to work around with clever targeting, because the targeting options to work around it do not yet exist.
What we will keep watching
The two items most likely to change this channel's usefulness for hair restoration clinics are a native conversions API and any expansion of targeting beyond broad topic categories. Until one or both arrive, we are treating ChatGPT Ads as an early test allocation inside a broader paid acquisition plan, not a stand-alone strategy.
SOP 03
Deciding whether ChatGPT Ads fits your clinic starts with the evidence, not the platform
Tell us about your clinic and we'll tell you whether pay-per-show fits, and whether ChatGPT Ads are worth testing for you.

